Active — Not RecruitingNot Applicable

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

United States810 participantsStarted 1997-12

Plain-language summary

Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non-institutional (community dwelling) woman of any race * Between 18-45 years at the first screening visit * Have regular menstrual cycles * Diagnosed with invasive breast cancer stage I, II, III within the previous eight months * Have physician agreement for patient participation Exclusion Criteria: * No menstrual bleeding cycles * Psychiatric or psychologic abnormality precluding the informed consent process or which would decrease compliance * Previous malignancy (excepting basal and squamous skin cancer and stage 0 cervical cancer) * Stage IV breast malignancy * Residency outside United States * No telephone

What they're measuring

The overall goal of the proposed research is to recruit and follow young breast cancer patients aged 45 and younger, in order to examine menstrual cycle maintenance.

Timeframe: Conclusion of the study

Trial details

NCT IDNCT00589654

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Amenorrhea trials